%0 Journal Article
%T Spontaneous Hemopericardium Complicated with Hemothorax in a Patient Receiving Edoxaban Therapy: A Case Report
%A Hsin-Bang Leu
%A Li-Wei Lo
%A Pai-Feng Hsu
%A Shih-Ann Chen
%A Tsung-Ying Tsai
%J Archive of "Acta Cardiologica Sinica".
%D 2019
%R 10.6515/ACS.201905_35(3).20190212A
%X The introduction of non-vitamin K antagonists oral anticoagulants (NOACs) has been a major stride in stroke prevention for atrial fibrillation (AF). Edoxaban, a factor Xa inhibitor, has a remarkable safety profile and efficacy.1 Spontaneous hemopericardium is a rare complication of oral anticoagulant and had been reported in patients taking warfarin,2,3 dabigatran,4 rivaroxaban,5 and apixaban.6 To our knowledge, our case is the first to report a spontaneous hemopericardium in a patient taking edoxaban
%K Case report
%K Complication
%K Edoxaban
%K Hemopericardium
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533573/